Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magic mushroom compound tested for stroke patients

NCT ID NCT07053917

First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 30 times

Summary

This study tests whether psilocybin, a psychedelic substance, is safe for people who had a stroke at least a year ago. Researchers will monitor blood pressure and other vital signs in 20 participants. The goal is to see if psilocybin can help with lingering symptoms like weakness or paralysis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21287, United States

Conditions

The condition(s) this trial relates to.

hemiplegia Hemorrhagic Stroke intracerebral hemorrhage Ischemic Stroke middle cerebral artery infarction Paresis stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.